Main Article Content
To delay the progression of end stage renal disease, the determination of risk factors of rapid glomerular filtration rate (GFR) decline in the early stage of kidney disease is crucial. The purpose of this retrospective cohort study was to identify factors associated with rapid GFR decline in patients with kidney disease. By using the systematic random sampling, 745 participants were included in the study. They were diagnosed with chronic kidney disease stage 1-3b and received health services at the outpatient department of Chumpae Hospital, Khon Kaen during 2015-2017. Multiple logistic regression was used to analyze the factors. The results showed that factors associated with rapid GFR decline were 1) Body Mass Index (BMI) [BMI<18.5 (ORadj 6.95, 95%CI 1.88-25.77); BMI 23-24.9 (ORadj 1.60, 95%CI 1.01-2.55)]; 2) systolic blood pressure>140 mmHg (ORadj 1.42, 95%CI 1.03-1.95); and 3) chronic kidney disease stage 2 (ORadj 1.50, 95%CI 1.01-2.23). Factors associated with the delay of rapid GFR decline were 1) age [age 41-60 years old (ORadj 0.40, 95%CI 0.17-0.97), age 60 years old and over (ORadj 0.37, 95% CI 0.15-0.89)]; and 2) chronic kidney disease stage 3b (ORadj 0.39, 95%CI 0.19-0.80)
1.Wu LW, Chen WL, Liaw FY, Sun YS, Yang HF, Wang CC,et al. Association between fluid intake and kidney function, and survival outcomes analysis: a nationwide population-based study. BMJ Open2016;6:1-8
2.Collin A J, Foley R N, Herzog C, Chavers B M, Gilbertson D, Ishani A& Murray A (2010). Excerpts from the US renal data system 2009annual data report. American journal of kidney diseases: the official journal of the National Kidney Foundation, 55(1Suppl1), S1. chronic renal disease. Seminars in Dialysis, 21(3), 206-209.
3.American kidney Fund. (2012) kidney disease statistic: Available from URL: http://www.kidneyfund.org/assets/pdf/kidney-disease-statistics.pdf/ Accessed on July 28, 2017.
4.IngsathitA, ThakkinstianA, Chaiprasert A, Sangthawan P, Gojaseni P, Kiattisunthorn K, et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephron Dial Transplant2010;25:1567-75.
5.HillNR, Fatoba ST, Oke JL, HirstJA, O’Callaghan CA, Lasserson DS,et al. Global prevalenceof chronic kidney disease - a systematic review and meta-analysis. PLoS One 2016;11:1-18.
6The Nephrology Society of Thailand. Thailand renal replacement therapyyear 2015. 2015 [cited 2018 Aug 20]. Available from: http://www.nephrothai.org/images/Final_TRT_ report_2015.
7.Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, et al. Assessment of global kidney health care status. Journal of the American Medical Association 2017;317(18):1864–1881ใฃ
8.Tantivess S, Werayingyong P, Chuengsaman P, Teerawattananon Y. Universal coverage of renal dialysis in Thailand: promise, progress,and prospects. BMJ (Clin Res Ed) 2013;1-6.
9.Sakthong P, &Kasemsup V (2011). Health -related quality of life in Thai peritoneal dialysis patients. Asian Biomedicine, 5(6), 799-806.
10.Wich K,Poosit P,Wiroad T.The economy needfor kidney replacement therapy of Thailand.Journal of Thai Renal [internet cited 2016 July 27] [.Available from: http://kb.hsri. or.th/dspace/bitstream/handle/11228/345/2006_DMJ84_
11.Thai Renal Replacement Therayp(TRT) Committee. (2012). TRT registry annual report. Nephrology Society of Thailand.
12.National K F. (2002). K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American journal of kidney diseases: the official journal of the National Kidney Foundation, 39(2 Suppl1), S1.
13.Whittier WL, Lewis EJ. Pathophysiology of chronic kidney disease. In: Gilbert SJ, Weiner DE, editors. National Kidney Foundation Primer on Kidney Diseases. 6th. Philadelphia: Elsevier/Saunders; 2014. p. 448-57.
14.Momchai S &SomjitA.Geriatic nephrology: Text Book of Nephrology. Bangkok; Bangkok Text and Journal pub.;2011 (in Thai)
15.Paveena S, Somjit A, Kajorn T, and Somchai T. Hypertension and kidney: Text Book of Nephrology. Bangkok ; Bangkok text and journal pub.;2011 (in Thai)
16.Paveena S,Somchai T.Overview of chronic kidney disease. :Text Book of Nephrology. Bangkok; Bangkok text and journal pub.;2011 (in Thai)
17.Buncha S. Commonly used kidney equations: Essential Nephrology.Bangkok; Na aksorn pub.;2012 (in Thai )
18.Lee SJ & Chung CW. 2014. Health Behaviors and Risk Factors Associated with Chronic Kidney Disease in Korean Patients with Diabetes : The Fourth Korean National Health and Nutritional Examination Survey. Asian Nursing Research, 8, 1, 8-14.
19. Cummings, DM, Larsen, LC, Doherty, L, Lea, CS , & Holbert, D. (2011). Glycemic Control Patterns and Kidney Disease Progression among Primary Care Patients with Diabetes Mellitus. The Journal of the American Board of Family Medicine, 24(4), 391–398.
20.Siriwong T. A practice guideline to slow down kidney degeneration for physician and healthcare providers year 2005). 2nd ed. Bangkok: SrimuengkarnpimCo,Ltd; 2005. (in Thai)
21. The Nephrology Society of Thailand. Clinical practice recommendation for the evaluation and management of chronic kidney disease in adults 2015. 2015 [cited 2018 Aug 20]. Available from: http://www.nephrothai.org.
22.JirubapaM. The Slowly Progressive Chronic Kidney Disease from Adult to Elder Persons. The Journal of Boromarajonani College of Nursing, Nakhonratchasima2014;20:5-15.
23.Tongsagra K. Chronic Kidney Disease in Text Book of Nephrology, Bangkok : Bangkok Text and Journal pub.;2011P. 1911-1924. (in Thai)
24.Chumpar hospital Data Statistical of Illness,2017 . (in Thai)
25.Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements,2013: 3(1), 136-150.
26.Ueda, H, Ishimura, E, Shoji, T, Emoto, M, Morioka, T, Matsumoto, N, Fukumoto, S, Miki, T, Inaba, M., and Nishizawa, Y. Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes. Diabetes Care 2003 May; 26(5): 1530-1534.
27.Hsieh F Y, Bloch, D A, & Larsen, M D. A simple method of sample size calculation for linear and logistic regression. Statistics in Medicine 1998: 17(14), 1623–34.
28.Vigil A,Condés E, Camacho R,Cobo G, Gallar P, Oliet A,Herrero J C. Predictors of a Rapid Decline of Renal Function in Patients with Chronic Kidney Disease Referred to a Nephrology Outpatient Clinic: A Longitudinal Study. Advances in Nephrology, 2015: 1–8.
29.Din U A AS El, Salem M M&Abdulazim D O. Stop chronic kidney disease progression: Time is approaching.World Journal of Nephrology. 2016: 5(3), 258-273.
30.Tawee S &Udom K.Top secret :How to prevented CKD.2005 [in Thai]
31.Vejakama P, Ingsathit, Attia J&Thakkinstian A.Epidemiological study of chronic kidney disease progression: a large-scale population-based cohort study. Medicine.2015). 94(4),1-8.
32.Grams M E, Yang W, Rebholz C M, Wang X, Porter A C, Inker L A. et al. (2016). Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Kidney Diseases, 1–10.
33.Utsumi K, Katsura K, Iino Y& Katayama Y. (2012). Blood pressure control in patients with chronic kidney disease. Journal of Nippon Medical School, 79(2), 111–114.
34.Hall, M E, Carmo, J M d, Silva, A A d, Juncos L A, Wang Z & Hall J E. (2014). Obesity, hypertension, and chronic kidney disease. International Journal of Nephrology and Renovascular Disease, (7), 75–88.
35.Nagel G, Zitt E, Peter R, PompellaA, Concin H&Lhotta K. (2013). Body mass index and metabolic factors predict glomerular filtration rate and albuminuria over 20 years in a high-risk population. BMC Nephrology, 14(177), 1-10.
36.Tsuruya K, Yoshida H, Nagata M, Kitazono T, Iseki K, Iseki, et al. (2015). Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of CKD: A longitudinal study in a large Japanese population. American Journal of Kidney Diseases, 66(6), 972–983.
37.Herrington W G, Smith M, Bankhead C, Matsushita K, Stevens S, Holt T. et al. (2017). Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England. Plos One, 12(3), 1-15.
38.Stephanie N& Chi-yuan H (2007). Excess weight as a risk factor for kidney failure. Current Opinion in Nephrology & Hypertension, 16(2), 71-76
39.Kwakernaak A J, Zelle D M, Bakker S J L &Navis G. (2013). Central Body Fat Distribution Associates with Unfavorable Renal Hemodynamics Independent of Body Mass Index. Journal of the American Society of Nephrology, 24(6), 987–994.
40.Wei L, MacDonald T, Jennings C, Sheng X, Flynn R W & Murphy M J(2013). Estimated GFR reporting is associated with decreased nonsteroidal anti-inflammatory drug prescribing and increased renal function. Kidney International, 84(1), 174–178.